Roid Rage Roid Rage

Write-ins

A Business Meeting

CONFIDENTIAL CONFIDENTIAL CONFIDENTIAL

PRT THREAT ASSESSMENT

Code Name: Roid Rage
Civilian Identity: Stephen Mulrood
Affiliation: Rogue, associated with the Iron Storm

Power Classification:
- Tinker 5 (sub: Brute 4, Trump 3; chemical bioenhancement specialty)

Abilities:
- Regenerative capabilities
- Creation of power-granting drugs, particularly regeneration
- Enhanced physical abilities through self-administration

Assessment:
Roid Rage is a biotinker with the ability to create gaseous drugs that grant effects on par with low-level powers.
As a result, he is considered a force multiplier for any group he aligns with.
The regenerative capabilities and physical enhancements he possesses make him a formidable combatant in his own right.

Strengths:
- Ability to heal severe injuries and regrow lost limbs
- Can grant temporary powers to allies
- Enhanced physical abilities

Weaknesses:
- Overuse of his creations leads to Thinker-like headaches and nosebleeds
- Reliant on his mask for power administration
- No ranged capabilities on record

Engagement Protocols:
1. Prioritize separating Roid Rage from his mask and chemical supplies.
2. Use containment foam to restrict his movement.
3. Employ long-range attacks to avoid close combat where his enhanced form is in play.
4. Be prepared for a variety of enhanced opponents if engaging his allies.
5. Have medical staff, preferably biotinkers, on standby in case of exposure to unknown chemical agents.

History:
Former medical student. Trigger event unknown.
Now operates as a rogue, selling his medical innovations, particularly regenerative gas.
Recently joined the crew of the Iron Storm.

Notes:
- Presumed to have access to extensive resources aboard the Iron Storm for his biotinkering.

Recommended Approach:
Roid Rage is not considered a threat at this time.
Due to his valuable medical abilities and non-hostile nature, maintaining a positive relationship is preferable to confrontation.

(Back)

Edit Report
Pub: 28 Jul 2024 12:42 UTC
Edit: 16 Sep 2024 11:25 UTC
Views: 135